Dennis E. Condon net worth and biography

Dennis Condon Biography and Net Worth

Director of Establishment Labs

Mr. Condon has served on our board since December 2017. He brings 35 years of experience in the plastic surgery sector, including the breast implant market as President of Mentor Aesthetics from 1990 to 1998. Most recently, Mr. Condon was the CEO and President of Nuvesse Skin Therapies, a venture-backed cosmeceutical skincare company serving the U.S. medical device and retail skin care markets, until its sale to a Korean pharmaceuticals company in 2016. Previous to Nuvesse, he was CEO and President of Merz Aesthetics, Inc. and President and Chief Business Officer of BioForm Medical. BioForm was acquired by Merz Pharma in January 2010. Mr. Condon has also lead other aesthetic companies, acting as CEO of a cosmetic laser company and CEO of a national chain of cosmetic surgery centers. Mr. Condon currently serves on the boards of two other companies in the aesthetic medical field: AirXpanders Inc., a unique breast reconstruction device, and Suneva Medical Inc., which commercializes the longest lasting dermal filler for facial fine lines and wrinkles. Mr. Condon has a BS in Biological Sciences from the University of California, Davis.

What is Dennis E. Condon's net worth?: The estimated net worth of Dennis E. Condon is at least $388,170.00 as of June 9th, 2021. Mr. Condon owns 9,000 shares of Establishment Labs stock worth more than $388,170 as of November 21st. This net worth approximation does not reflect any other assets that Mr. Condon may own. Learn More about Dennis E. Condon's net worth.
How do I contact Dennis E. Condon?: The corporate mailing address for Mr. Condon and other Establishment Labs executives is Building B15 and 25 Coyol Free Zone, Alajuela G2, . Establishment Labs can also be reached via phone at (062) 434-2400 and via email at [email protected]. Learn More on Dennis E. Condon's contact information.
Has Dennis E. Condon been buying or selling shares of Establishment Labs?: Dennis E. Condon has not been actively trading shares of Establishment Labs during the last ninety days. Most recently, Dennis E. Condon sold 9,000 shares of the business's stock in a transaction on Friday, September 10th. The shares were sold at an average price of $73.50, for a transaction totalling $661,500.00. Following the completion of the sale, the director now directly owns 9,000 shares of the company's stock, valued at $661,500. Learn More on Dennis E. Condon's trading history.
Who are Establishment Labs' active insiders?: Establishment Labs' insider roster includes Juan Chacon-Quiros (Founder), Dennis Condon (Director), Roberto de Mezerville (CTO), Renee Gaeta (CFO), Lisa Gersh (Director), Nicholas Lewin (Director), and Edward Schutter (Director). Learn More on Establishment Labs' active insiders.
Are insiders buying or selling shares of Establishment Labs?: During the last twelve months, Establishment Labs insiders bought shares 1 times. They purchased a total of 2,000 shares worth more than $54,080.00. During the last twelve months, insiders at the sold shares 3 times. They sold a total of 14,346 shares worth more than $647,806.00. The most recent insider tranaction occured on July, 11th when CEO Quiros Juan Jose Chacon sold 3,641 shares worth more than $163,990.64. Insiders at Establishment Labs own 11.4% of the company. Learn More about insider trades at Establishment Labs.
Information on this page was last updated on 7/11/2024.

Dennis E. Condon Insider Trading History at Establishment Labs

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
9/10/2021	Sell	9,000	$73.50	$661,500.00	9,000
6/9/2021	Sell	9,000	$79.01	$711,090.00	9,000

Dennis E. Condon Buying and Selling Activity at Establishment Labs

Establishment Labs Company Overview

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

Today's Range

Now: $43.13

$41.50

$43.18

50 Day Range

MA: $42.97

$37.51

$48.81

2 Week Range

Now: $43.13

$22.05

$60.12

Volume

187,605 shs

Average Volume

388,431 shs

Market Capitalization

$1.21 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.2

From Porter & Company | Ad

The AI boom is just getting started. And the real wealth has still to be made…

You must read this new presentation from Porter Stansberry.